01 Mar 2025
In the March/April issue of Clinical Laboratory News, Margery Connelly, PhD, strategic director of diagnostics research and development at Labcorp, discusses the growing public health challenge of undiagnosed liver disease. With liver conditions like NAFLD and NASH often going unnoticed until advanced stages, Dr. Connelly explores the critical need for earlier, noninvasive diagnostics. She emphasizes how innovations in biomarker research and accessible testing could improve outcomes and ease the burden on healthcare systems. Read the full article in Clinical Laboratory News to learn how Labcorp scientists are working to decode this silent epidemic.